Metabolismo
Los inhibidores del metabolismo son compuestos que interfieren con las vías metabólicas, alterando la producción y utilización de energía dentro de las células. Estos inhibidores se utilizan para estudiar la regulación del metabolismo, el papel de las vías metabólicas en enfermedades como el cáncer y la diabetes, y para desarrollar nuevas estrategias terapéuticas. Los inhibidores del metabolismo pueden dirigirse a diversas enzimas y procesos involucrados en la glucólisis, la oxidación de ácidos grasos y otras funciones metabólicas. En CymitQuimica, ofrecemos una amplia gama de inhibidores del metabolismo de alta calidad para apoyar su investigación en bioquímica, trastornos metabólicos y desarrollo de fármacos.
Subcategorías de "Metabolismo"
- AhR(42 productos)
- Aminopeptidasa(76 productos)
- CETP(20 productos)
- Anhídrido carbónico(197 productos)
- Caseína quinasa(137 productos)
- DHFR(34 productos)
- Descarboxilasa(4 productos)
- Deshidrogenasa(302 productos)
- FAAH(66 productos)
- FXR(62 productos)
- Factor Xa(87 productos)
- Ácido graso sintasa(37 productos)
- Ferroptosis(226 productos)
- GR(3 productos)
- GSNOR(4 productos)
- Glucoquinasa(57 productos)
- HIF / HIF Prolilhidroxilasa(146 productos)
- HMG-CoA reductasa(33 productos)
- Hidroxilasa(35 productos)
- IDO(84 productos)
- LDL(8 productos)
- Lipasa(107 productos)
- Lípido(61 productos)
- Lipoxigenasa(134 productos)
- MAO(87 productos)
- MPO(2 productos)
- NAMPT(40 productos)
- P450(6 productos)
- PAI-1(26 productos)
- PDE(167 productos)
- PED(1 productos)
- PKM(17 productos)
- PPAR(169 productos)
- Fosfolipasa(83 productos)
- ROR(47 productos)
- Receptor de retinoides(28 productos)
- SGK(11 productos)
- Tiorredoxina(12 productos)
- Transferasa(29 productos)
- Transportador(46 productos)
- UGT(4 productos)
- Inhibidores de la xantina oxidasa (XO)(9 productos)
Mostrar 34 subcategorías más
Se han encontrado 9280 productos de "Metabolismo"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
ICMT-IN-39
CAS:ICMT-IN-39, also known as compound 18, functions as an inhibitor of ICMT with an IC50 value of 0.031 µM [1].Fórmula:C22H29NOForma y color:SolidPeso molecular:323.47Lp-PLA2-IN-2
CAS:Lp-PLA2-IN-2 is a selective and potent lipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitor, with an IC50 0f 120 nM for recombinant human Lp-PLA2.Fórmula:C19H23FN2O4SPureza:98%Forma y color:SolidPeso molecular:394.461,2-Dilauroyl-sn-glycero-3-PA sodium
CAS:DLPA is a phosphatidic acid (PA) that incorporates the medium-chain lauric acid (12:0).Fórmula:C27H52O8PNaForma y color:SolidPeso molecular:558.66DPM-1001 trihydrochloride
DPM-1001 trihydrochloride: Potent PTP1B inhibitor, IC50 100 nM, oral, non-competitive, anti-diabetic.Fórmula:C35H60Cl3N3O3Forma y color:SolidPeso molecular:677.23EMD638683 S-Form
CAS:EMD638683 is a highly selective SGK1 inhibitor with IC50 of 3 μM. EMD638683 S-Form is the S-form of EMD638683.Fórmula:C18H18F2N2O4Forma y color:SolidPeso molecular:364.34Docosatrienoic Acid
CAS:Docosatrienoic acid is a rare omega-3 fatty acid; Ki value is 5×M, which inhibits the binding of LTB4 to porcine neutrophil membrane.Fórmula:C22H38O2Pureza:98%Forma y color:SolidPeso molecular:334.54Prolyl Hydroxylase inhibitor 1
CAS:Prolyl Hydroxylase inhibitor 1 is an orally active inhibitor of hypoxia inducible factor (HIF)-prolyl hydroxylase (PHD) (IC50 of 62.23 nM).Fórmula:C19H18ClN5O4Pureza:98%Forma y color:SolidPeso molecular:415.83EMT inhibitor-2
CAS:EMT inhibitor-2 blocks CYP3A4 and CYP2C9 (IC50: 49.72, 5.54 μM) and prevents IL-1β/TGF-β-induced EMT.Fórmula:C24H26N2O8Forma y color:SolidPeso molecular:470.47ICMT-IN-50
CAS:ICMT-IN-50 (compound 3) serves as an inhibitor of ICMT with an IC50 value of 0.31 µM [1].Fórmula:C27H31NO3Forma y color:SolidPeso molecular:417.54ICMT-IN-42
CAS:ICMT-IN-42 (compound 21) serves as an ICMT inhibitor, demonstrating potency with an IC50 of 0.054 μM [1].Fórmula:C23H31NOForma y color:SolidPeso molecular:337.5PDE1-IN-2
CAS:PDE1-IN-2 is an PDE1 inhibitor(PDE1C, PDE1B and PDE1A with IC50 values of 6, 140 and 164 nM, respectvely).Fórmula:C16H21BrN4O2Pureza:98%Forma y color:SolidPeso molecular:381.271-Palmitoyl-2-Lauroyl-sn-glycero-3-PC
CAS:1-Palmitoyl-2-lauroyl-sn-glycero-3-PC (1,2-PLPC) is a phospholipid with palmitoyl (16:0) and lauryl (12:0) acyl chains at the sn-1 and sn-2 positions, respectively. This mixed-chain phosphatidylcholine aids in researching the role of chain-chain contact interactions in maintaining the structural stability of lipid membrane bilayers.Fórmula:C36H72NO8PForma y color:SolidPeso molecular:677.945LXR agonist 1
CAS:Potent LXR agonist; AC50: 1.5 nM (LXR-α), 12 nM (LXR-β); potential in atherosclerosis research.Fórmula:C27H26F3N3O3SForma y color:SolidPeso molecular:529.57Enpp-1-IN-4
CAS:Enpp-1-IN-4: potent enpp-1 inhibitor with potential in cancer research. See patent WO2019177971A1, compound 1.Fórmula:C19H19N5O5SForma y color:SolidPeso molecular:429.45CETP-IN-3
CAS:CETP-IN-3 is an inhibitor of the plasma glycoprotein cholesterol ester transfer protein (CETP), elevating HDL-C through inhibition of CETP.Fórmula:C30H24F12N2O4Pureza:98%Forma y color:SolidPeso molecular:704.5Dendrogenin A
CAS:Dendrogenin A (DDA) is a compound acting as a selective liver X receptor (LXR) modulator, cholesterol epoxide hydrolase inhibitor (Ki = 120 nM), and a metabolicFórmula:C32H55N3O2Forma y color:SolidPeso molecular:513.80Methyl γ-Linolenyl Fluorophosphonate
CAS:MγLnFP, an analog of methyl arachidonyl fluozophosphonate (MAFP), holds significance in pharmacological research due to its potential as an inhibitor of phospholipases, FAAH, and its role as a CB receptor ligand. However, the properties and effects of the γ-linolenyl variant of MAFP remain to be fully explored.Fórmula:C19H34FO2PForma y color:SolidPeso molecular:344.451Homonojirimycin
CAS:Homonojirimycin is an alpha-glucosidase inhibitor.Fórmula:C7H15NO5Pureza:98%Forma y color:SolidPeso molecular:193.2ICMT-IN-13
CAS:ICMT-IN-13 (compound 49) functions as an inhibitor of ICMT, exhibiting an IC50 value of 0.47 μM [1].Fórmula:C21H25ClFNOForma y color:SolidPeso molecular:361.88244cis
CAS:244cis, an ionizable cationic lipid incorporating a piperazine structure, facilitates the creation of lipid nanoparticles (LNPs). These LNPs, when formulated with 244cis and coated with an mRNA reporter gene, exhibit preferential accumulation in the lungs of mice, in contrast to those formulated with SM-102. Additionally, it leads to a reduction in the levels of serum chemokine (C-C motif) ligand 2 (CCL2) [1].Fórmula:C60H111N3O6Forma y color:SolidPeso molecular:970.54
